tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Vamil Divan, 331 are a BUY (69.1%), 135 are a HOLD (28.18%), 13 are a SELL (2.71%).
Analyst Vamil Divan, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 60.64% that have a potential upside of 49.17% achieved within 349 days.
Vamil Divan’s has documented 940 price targets and ratings displayed on 55 stocks. The coverage is on Healthcare, Financial Services, Technology sectors.
Most recent stock forecast was given on MRK, Merck mpany.
Analyst best performing recommendations are on ARAV (ARAVIVE).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%) receiving and performance score of 69.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$57.88 (22.51%)
$265
Buy Since 12-Sep-2025
$303
$45.88 (17.84%)
$298
23 days ago
(20-Aug-2026)
2/8 (25%)
$41.17 (15.72%)
35
Buy Since 08-Dec-2021
$300
$42.88 (16.68%)
$295
26 days ago
(17-Aug-2026)
9/11 (81.82%)
$49.67 (19.84%)
469
Buy Since 23-Jan-2023
$260
$2.88 (1.12%)
$235
1 months 2 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
127
Buy Since 06-Feb-2020
$288
$30.88 (12.01%)
$261
1 months 8 days ago
(04-Aug-2026)
36/37 (97.3%)
$44.2 (18.13%)
434
Which stock is Vamil Divan most bullish on?
Which stock is Vamil Divan most reserved on?
What Year was the first public recommendation made by Vamil Divan?
